What 18 F-FDG PET Response-Assessment Method Best Predicts Survival After Curative-Intent Chemoradiation in Non-Small Cell Lung Cancer: EORTC, PERCIST, Peter Mac Criteria, or Deauville Criteria?

Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine
Guy-Anne TurgeonMichael P Mac Manus

Abstract

The optimal methodology for defining response with 18F-FDG PET after curative-intent chemoradiation for non-small cell lung cancer (NSCLC) is unknown. We compared survival outcomes according to the criteria of the European Organization for Research and Treatment of Cancer (EORTC), PERCIST 1.0, the Peter Mac metabolic visual criteria, and the Deauville criteria, respectively. Methods: Three prospective trials of chemoradiation for NSCLC, involving baseline and posttreatment 18F-FDG PET/CT imaging, were conducted between 2004 and 2016. Responses were categorized as complete metabolic response (CMR), partial metabolic response, stable metabolic disease, or progressive metabolic disease. Cox proportional-hazards models and log-rank tests assessed the impact of each response on overall survival (OS). Results: Eighty-seven patients underwent 18F-FDG PET/CT before and after radical chemoradiation for NSCLC. Follow-up 18F-FDG PET/CT scans were performed at a median of 89 d (interquartile range, 79-93 d) after radiotherapy. Median follow-up and OS after PET response imaging were 49 and 28 mo, respectively. Interobserver agreements for EORTC, PERCIST, Peter Mac, and Deauville had κ values of 0.76, 0.76, 0.87, and 0.84, respectively. All ...Continue Reading

References

Feb 16, 2000·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·H YoungP Price
Mar 29, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Michael P Mac ManusDavid L Ball
Nov 25, 2004·The Annals of Thoracic Surgery·Robert J CerfolioAlfred A Bartolucci
Jun 14, 2005·Lung Cancer : Journal of the International Association for the Study of Lung Cancer·Michael P Mac ManusDavid L Ball
Jul 20, 2007·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Feng-Ming Spring KongTheodore S Lawrence
Jun 24, 2009·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Richard L WahlMartin A Lodge
Jun 23, 2009·Leukemia & Lymphoma·Michel MeignanCorinne Haioun
May 28, 2010·European Journal of Nuclear Medicine and Molecular Imaging·Sally F BarringtonMichael J O'Doherty
Apr 2, 2013·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·Michael P Mac ManusRodney J Hicks
Aug 13, 2014·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Sally F BarringtonBruce D Cheson
Feb 4, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Sara SheikhbahaeiRathan M Subramaniam
Nov 24, 2016·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Mateen C MoghbelLale Kostakoglu
Apr 1, 2017·European Journal of Nuclear Medicine and Molecular Imaging·Katja PinkerWolfgang A Weber
May 12, 2017·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Joan FledeliusPeter Meldgaard
Sep 9, 2017·The New England Journal of Medicine·Scott J AntoniaUNKNOWN PACIFIC Investigators

❮ Previous
Next ❯

Citations

Mar 10, 2019·Molecular Imaging and Biology : MIB : the Official Publication of the Academy of Molecular Imaging·Maria Vittoria MattoliAlessandro Giordano
Jun 20, 2020·AJR. American Journal of Roentgenology·Kevin P BanksMichael N Clemenshaw
Apr 18, 2020·The Annals of Thoracic Surgery·Atsushi KagimotoMorihito Okada

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Imaging

Imaging techniques, including CT and MR, have become essential to tumor detection, diagnosis, and monitoring. Here is the latest research on cancer imaging.

Cancer Metabolism

In order for cancer cells to maintain rapid, uncontrolled cell proliferation, they must acquire a source of energy. Cancer cells acquire metabolic energy from their surrounding environment and utilize the host cell nutrients to do so. Here is the latest research on cancer metabolism.

Cancer Metabolism: Therapeutic Targets

Targeting the mechanisms by which cancer cells acquire energy for metabolic needs is a therapeutic target. Discover the latest research on cancer metabolism and therapeutic targets.